Ownership history in ALGERT GLOBAL LLC · 14 quarters on record
This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in ENANTA PHARMACEUTICALS INC (ENTA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 11,106 | -18,258 | -62.2% | 0.00% | $133K | $11.97 |
| 2023 Q3 | UNCHANGED | 29,364 | — | 0% | 0.02% | $328K | $11.17 |
| 2023 Q2 | ADDED | 29,364 | +12,160 | +70.7% | 0.03% | $628K | $21.40 |
| 2023 Q1 | ADDED | 17,204 | +724 | +4.4% | 0.03% | $696K | $40.44 |
| 2022 Q4 | REDUCED | 16,480 | -7,030 | -29.9% | 0.04% | $767K | $46.52 |
| 2022 Q3 | REDUCED | 23,510 | -5,510 | -19.0% | 0.07% | $1.2M | $51.87 |
| 2022 Q2 | ADDED | 29,020 | +10,560 | +57.2% | 0.10% | $1.4M | $47.27 |
| 2022 Q1 | ADDED | 18,460 | +15,151 | +457.9% | 0.09% | $1.3M | $71.18 |
| 2019 Q2 | REDUCED | 3,309 | -9,877 | -74.9% | 0.10% | $279K | $84.38 |
| 2019 Q1 | REDUCED | 13,186 | -9,279 | -41.3% | 0.72% | $1.3M | $95.52 |
As of 2025 Q4 — sorted by position size